A study suggests that a novel CAR T-cell therapy could be a curative treatment for some patients with chronic lymphocytic leukemia, with 25% of responders still in remission after 6 years.
Sabrina Serani
Advertisement
Articles by Sabrina Serani
Advertisement
Latest Updated Articles
CAR T-cell Therapy Shows 6-Year Durability in CLL PatientsPublished: February 23rd 2024 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
People With Multiple Sclerosis Have Distinct Oral Microbiome, Study Shows
2
ICER Analysis Finds Net Prices of New Drugs Rose 51% Over Three Years
3
Key Efficacy and Safety Data from the EMERALD Trial
4
Obesity Is Now Also a Problem for People With Type 1 Diabetes
5
